標(biāo)題: Titlebook: Biomarkers in Liver Disease; Vinood B. Patel,Victor R. Preedy Reference work 2017 Springer Science+Business Media Dordrecht 2017 Applicati [打印本頁(yè)] 作者: False-Negative 時(shí)間: 2025-3-21 19:10
書(shū)目名稱Biomarkers in Liver Disease影響因子(影響力)
書(shū)目名稱Biomarkers in Liver Disease影響因子(影響力)學(xué)科排名
書(shū)目名稱Biomarkers in Liver Disease網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱Biomarkers in Liver Disease網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱Biomarkers in Liver Disease被引頻次
書(shū)目名稱Biomarkers in Liver Disease被引頻次學(xué)科排名
書(shū)目名稱Biomarkers in Liver Disease年度引用
書(shū)目名稱Biomarkers in Liver Disease年度引用學(xué)科排名
書(shū)目名稱Biomarkers in Liver Disease讀者反饋
書(shū)目名稱Biomarkers in Liver Disease讀者反饋學(xué)科排名
作者: 吞下 時(shí)間: 2025-3-21 22:51
,The Reconstruction of Konrad Zuse’s Z3,. In addition, Hepascore is dynamic over time and has been demonstrated to predict adverse clinical outcomes in longitudinal cohorts of chronic hepatitis C and alcoholic liver disease patients. Thus, Hepascore is a valuable clinical tool to stage liver fibrosis and determine prognosis, need for trea作者: 可憎 時(shí)間: 2025-3-22 04:26
,Zuse’s Computer for Binary Logic,atients with ESLD have a high risk of dying such as surgery, alcoholic hepatitis, acute liver failure, and variceal bleeding. Since the MELD score was introduced, there have been several modifications that may have increased effectiveness in certain situations. The MELD score is not an accurate biom作者: 致詞 時(shí)間: 2025-3-22 07:06 作者: FLOAT 時(shí)間: 2025-3-22 12:29
https://doi.org/10.1007/978-3-531-91170-0rtal hypertension, including serum biomarkers and imaging techniques. Various serum molecules have been investigated for their ability to predict the presence of portal hypertension, some of which have showed to either correlate with the hepatic venous pressure gradient or predict clinically signifi作者: lobster 時(shí)間: 2025-3-22 13:17 作者: COM 時(shí)間: 2025-3-22 18:13 作者: gangrene 時(shí)間: 2025-3-22 22:59
https://doi.org/10.1007/978-3-531-91170-0modeling leads to a range of formation and disease-relevant degradation products of extracellular and intracellular proteins into the circulation. These fragments may provide information about the pathogenesis of disease and serve as serological biomarker targets. Clinically there is a need to ident作者: SUGAR 時(shí)間: 2025-3-23 03:55
https://doi.org/10.1007/978-3-531-91170-0een evaluated in liver diseases, and significant alterations have been found. Detailed understanding of the role of sialic acid, sialidases, and sialyltransferases and their interactions in liver diseases may significantly contribute to open new exciting frontiers of basic and therapeutic exploratio作者: 變色龍 時(shí)間: 2025-3-23 09:11 作者: 厚顏無(wú)恥 時(shí)間: 2025-3-23 13:25 作者: notification 時(shí)間: 2025-3-23 16:19 作者: AVID 時(shí)間: 2025-3-23 21:19 作者: GUILE 時(shí)間: 2025-3-23 23:30 作者: Pageant 時(shí)間: 2025-3-24 06:14 作者: observatory 時(shí)間: 2025-3-24 07:30 作者: Annotate 時(shí)間: 2025-3-24 11:10
Serum Biomarkers for Evaluating Portal Hypertensionrtal hypertension, including serum biomarkers and imaging techniques. Various serum molecules have been investigated for their ability to predict the presence of portal hypertension, some of which have showed to either correlate with the hepatic venous pressure gradient or predict clinically signifi作者: Gorilla 時(shí)間: 2025-3-24 17:03 作者: 埋伏 時(shí)間: 2025-3-24 22:35
Biomarkers to Monitor Graft Function Following Liver Transplantation(albumin, bilirubin, prothrombin time). Novel genetic markers such as microRNAs also show potential as more accurate or specific biomarker for various types of injury and functions. Some of these serum biomarkers were shown to be promising in predicting disease or severity of injury when measured in作者: Merited 時(shí)間: 2025-3-24 23:28 作者: liaison 時(shí)間: 2025-3-25 04:33
Interaction of Sialyltransferases, Sialidases, and Sialic Acids in Liver Diseases and Applications teen evaluated in liver diseases, and significant alterations have been found. Detailed understanding of the role of sialic acid, sialidases, and sialyltransferases and their interactions in liver diseases may significantly contribute to open new exciting frontiers of basic and therapeutic exploratio作者: Junction 時(shí)間: 2025-3-25 10:08
AST-to-Platelet Ratio Index (APRI) as Marker in Liver Diseaseant fibrosis. It showed promising results for predicting the presence of fibrosis in pediatric patients with NAFLD. Transient elastography, a noninvasive and objective but expensive method, showed higher performance in diagnosing significant fibrosis than APRI.作者: Pessary 時(shí)間: 2025-3-25 13:08
Soluble CD163 (sCD163): Biomarker of Kupffer Cell Activation in Liver Diseasecant fibrosis exceeding standard diagnostic scores such as APRI and FIB-4. Lower levels are found in nonalcoholic fatty liver disease (NAFLD), but sCD163 adds diagnostic information on the important identification of patients with advanced disease..The emerging picture from the increasing number of 作者: spondylosis 時(shí)間: 2025-3-25 16:06
CD133 and EpCAM as Biomarkers in Liver Diseasesdifferentiation, migration, and cell survival. Wnt/β-catenin signaling pathway is the major pathway involved in EpCAM-positive hepatic cancers. CD133 and EpCAM have several significant clinical implications in diagnosis, prognosis, and therapy of human liver cancers. Recently defined histological ty作者: Mercantile 時(shí)間: 2025-3-25 22:07
Graft-Derived Cell-Free DNA as a Biomarker in Liver Transplantationr more effective treatment intervention. It is especially helpful to guide changes in immunosuppression and to monitor immunosuppression minimization. This new approach may contribute to achieve more effective, less toxic personalized immunosuppression.作者: 原始 時(shí)間: 2025-3-26 03:37
https://doi.org/10.1007/978-94-007-7675-3Application to prognosis; Biomarkers in disease; Cancer Research; Discovery of biomarkers; High throughp作者: 災(zāi)禍 時(shí)間: 2025-3-26 06:52 作者: mercenary 時(shí)間: 2025-3-26 11:33 作者: chondromalacia 時(shí)間: 2025-3-26 13:14
Biomarkers in Disease: Methods, Discoveries and Applicationshttp://image.papertrans.cn/b/image/187816.jpg作者: 勤勞 時(shí)間: 2025-3-26 18:11 作者: entreat 時(shí)間: 2025-3-27 00:06 作者: Anthem 時(shí)間: 2025-3-27 01:06
,The Reconstruction of Konrad Zuse’s Z3, influences management. Histopathological staging of liver biopsy is considered the gold standard for assessment of liver fibrosis but is limited by its invasive nature, high cost, and sampling error. Hepascore is a serum model consisting of hyaluronic acid, bilirubin, alpha2-macroglobulin, gamma-gl作者: chuckle 時(shí)間: 2025-3-27 06:43 作者: ASSAY 時(shí)間: 2025-3-27 12:27 作者: 表示問(wèn) 時(shí)間: 2025-3-27 15:45
https://doi.org/10.1007/978-3-531-91170-0rkers that offer the advantage of being an objective, quantifiable, and reproducible measure. The most common applications of biomarkers include diagnosis, screening and monitoring of disease, assessment of response during therapy, risk assessment, and prognosis. Metabolomics or metabonomics enables作者: Vasoconstrictor 時(shí)間: 2025-3-27 18:15
https://doi.org/10.1007/978-3-531-91170-0mpounds is associated with beneficial effects on chronic diseases, including liver diseases. The aim of this chapter is to provide a comprehensive overview of the effect of nutritional interventions on liver biomarkers in animal models, with emphasis on the participation of functional foods and inte作者: 招人嫉妒 時(shí)間: 2025-3-27 22:44 作者: 間諜活動(dòng) 時(shí)間: 2025-3-28 03:21
https://doi.org/10.1007/978-3-531-91170-0and treatment. Recurrence is the main cause of death in patients who received curative treatment for the primary cancer. Tumors arising within 2 years of treatment typically originate from the primary tumour. These recurrent tumours tend to be aggressive and result in high mortality rate for these p作者: 小淡水魚(yú) 時(shí)間: 2025-3-28 09:55
https://doi.org/10.1007/978-3-531-91170-0s, but poor initial graft quality and complications following transplantation still limit patient and graft survival. Monitoring and evaluation of graft quality during follow-up is achieved by routine biomarker measurements in recipients’ blood, starting directly following surgery and in the months 作者: 舊石器時(shí)代 時(shí)間: 2025-3-28 13:20
https://doi.org/10.1007/978-3-531-91170-0d accumulation of extracellular matrix proteins, ultimately leading to loss of organ function. The extracellular matrix consists of fibrous and nonfibrous macromolecules such as collagens, elastin, and proteoglycans..During progressive fibrosis the balance of extracellular matrix remodeling is alter作者: arthroplasty 時(shí)間: 2025-3-28 16:00 作者: GROWL 時(shí)間: 2025-3-28 18:47
https://doi.org/10.1007/978-3-531-91170-0it might also be detected in muscle cells. In contrast to other markers of liver cell integrity like ASAT or Lactate Dehydrogenase, ALAT is highly specific for liver diseases. The sensitivity of elevated ALAT for hepatopathies is as high as 84% in large studies. The life span of a human liver cell i作者: Commission 時(shí)間: 2025-3-29 02:15
Konsens – der Grund der Legitimit?ts of patients with liver disorders. All prognostic scores for liver diseases include bilirubin in their calculations, and some studies have shown that bilirubin is an independent biomarker of mortality risk. We know that a high total bilirubin level is an indicator of disease, but nowadays there is 作者: Chagrin 時(shí)間: 2025-3-29 03:36 作者: 寬宏大量 時(shí)間: 2025-3-29 10:53 作者: 前奏曲 時(shí)間: 2025-3-29 13:55 作者: 下邊深陷 時(shí)間: 2025-3-29 15:58 作者: 箴言 時(shí)間: 2025-3-29 20:03
Traditional Markers in Liver Disease physicians can be helped by specific markers used to diagnose and follow up liver diseases. In fact some of the enzymes and the end products of the metabolic pathway occurring in the liver are very sensitive for the abnormality occurred and, for this reason, may be considered as biochemical markers作者: 情感脆弱 時(shí)間: 2025-3-30 00:12
Hepascore and Its Application to Liver Disease influences management. Histopathological staging of liver biopsy is considered the gold standard for assessment of liver fibrosis but is limited by its invasive nature, high cost, and sampling error. Hepascore is a serum model consisting of hyaluronic acid, bilirubin, alpha2-macroglobulin, gamma-gl作者: Itinerant 時(shí)間: 2025-3-30 04:33
Model for End-Stage Liver Disease (MELD) Score as a Biomarkertive. The model for end-stage liver disease (MELD) score was developed and is an accurate biomarker of 90-day mortality in patients with ESLD, essentially measuring how sick a patient is. The MELD score incorporates serum bilirubin, creatinine, and INR in a mathematical formula. Since 2002, the MELD作者: 偶然 時(shí)間: 2025-3-30 10:54 作者: GRUEL 時(shí)間: 2025-3-30 16:20 作者: insolence 時(shí)間: 2025-3-30 17:00
Liver Biomarkers and Their Applications to Nutritional Interventions in Animal Studiesmpounds is associated with beneficial effects on chronic diseases, including liver diseases. The aim of this chapter is to provide a comprehensive overview of the effect of nutritional interventions on liver biomarkers in animal models, with emphasis on the participation of functional foods and inte作者: BAIL 時(shí)間: 2025-3-30 21:26
Serum Biomarkers for Evaluating Portal Hypertensionn is responsible for the pathogenesis of most frequent and fatal complications of cirrhosis. It is of most importance to evaluate patients newly diagnosed with cirrhosis for the presence of clinically significant portal hypertension and associated complications, which could expose the patient to fat作者: 冒煙 時(shí)間: 2025-3-31 01:34 作者: 使成整體 時(shí)間: 2025-3-31 05:34
Biomarkers to Monitor Graft Function Following Liver Transplantations, but poor initial graft quality and complications following transplantation still limit patient and graft survival. Monitoring and evaluation of graft quality during follow-up is achieved by routine biomarker measurements in recipients’ blood, starting directly following surgery and in the months 作者: Ganglion-Cyst 時(shí)間: 2025-3-31 11:04 作者: 強(qiáng)制性 時(shí)間: 2025-3-31 13:52 作者: 松軟無(wú)力 時(shí)間: 2025-3-31 21:06
Biomarkers in Focus: Alanine Aminotransferaseit might also be detected in muscle cells. In contrast to other markers of liver cell integrity like ASAT or Lactate Dehydrogenase, ALAT is highly specific for liver diseases. The sensitivity of elevated ALAT for hepatopathies is as high as 84% in large studies. The life span of a human liver cell i作者: RAG 時(shí)間: 2025-4-1 00:35
